Menu
Back to Journals » Cancer Management and Research » Volume 6 » default
Cancer Management and Research
ISSN: 1179-1322
- View all (4485)
- Volume 15, 2023 (44)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Archive: Volume 6, 2014
Biliary stenting in advanced malignancy: an analysis of predictive factors for survival
Afshar M, Khanom K, Ma YT, Punia P
Cancer Management and Research 2014, 6:475-479
Published Date: 10 December 2014
Malignant phyllodes tumor of the breast presenting with hypoglycemia: a case report and literature review
Pacioles T, Seth R, Orellana C, John I, Panuganty V, Dhaliwal R
Cancer Management and Research 2014, 6:467-473
Published Date: 8 December 2014
Survival benefit of adjuvant radiotherapy in stage III and IV bladder cancer: results of 170 patients
Bayoumi Y, Heikal T, Darweish H
Cancer Management and Research 2014, 6:459-465
Published Date: 27 November 2014
Single fraction radiotherapy versus multiple fraction radiotherapy for bone metastases in prostate cancer patients: comparative effectiveness
Yoon F, Morton GC
Cancer Management and Research 2014, 6:451-457
Published Date: 25 November 2014
A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer
Cuyún Carter G, Barrett AM, Kaye JA, Liepa AM, Winfree KB, John WJ
Cancer Management and Research 2014, 6:437-449
Published Date: 23 October 2014
Higher susceptibility of NOD/LtSz-scid Il2rg-/- NSG mice to xenotransplanted lung cancer cell lines
Kanaji N, Tadokoro A, Susaki K, Yokokura S, Ohmichi K, Haba R, Watanabe N, Bandoh S, Ishii T, Dobashi H, Matsunaga T
Cancer Management and Research 2014, 6:431-436
Published Date: 21 October 2014
Preventative therapies for healthy women at high risk of breast cancer
Sestak I
Cancer Management and Research 2014, 6:423-430
Published Date: 17 October 2014
MicroRNA dysregulation as a prognostic biomarker in colorectal cancer
Dong Y, Yu J, Ng SS
Cancer Management and Research 2014, 6:405-422
Published Date: 14 October 2014
Targeting the MET receptor tyrosine kinase in non-small cell lung cancer: emerging role of tivantinib
Agwa ES, Ma PC
Cancer Management and Research 2014, 6:397-404
Published Date: 4 October 2014
Clinical implications of recent studies using mTOR inhibitors to treat advanced hormone receptor-positive breast cancer
Arena F
Cancer Management and Research 2014, 6:389-395
Published Date: 6 October 2014
The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients
Poulsen HS, Urup T, Michaelsen SR, Staberg M, Villingshøj M, Lassen U
Cancer Management and Research 2014, 6:373-387
Published Date: 26 September 2014
Interpreting overall survival results when progression-free survival benefits exist in today's oncology landscape: a metastatic renal cell carcinoma case study
Tang Y, Bycott P, Åkerborg Ö, Jönsson L, Negrier S, Chen C
Cancer Management and Research 2014, 6:365-371
Published Date: 22 September 2014
Dexrazoxane for the treatment of chemotherapy-related side effects
Langer SW
Cancer Management and Research 2014, 6:357-363
Published Date: 15 September 2014
Treating advanced melanoma: current insights and opportunities
Tronnier M, Mitteldorf C
Cancer Management and Research 2014, 6:349-356
Published Date: 10 September 2014
Is extended-field concurrent chemoradiation an option for radiologic negative paraaortic lymph node, locally advanced cervical cancer?
Asiri MA, Tunio MA, Mohamed R, Bayoumi Y, Alhadab A, Saleh RM, AlArifi MS, Alobaid A
Cancer Management and Research 2014, 6:339-348
Published Date: 9 September 2014
Palonosetron in the management of chemotherapy- induced nausea and vomiting in patients receiving multiple-day chemotherapy
Affronti ML, Bubalo J
Cancer Management and Research 2014, 6:329-337
Published Date: 5 September 2014
Interstitial fluid flow in cancer: implications for disease progression and treatment
Munson JM, Shieh AC
Cancer Management and Research 2014, 6:317-328
Published Date: 19 August 2014
Fertility preservation and GnRHa for chemotherapy: debate
Blumenfeld Z
Cancer Management and Research 2014, 6:313-315
Published Date: 19 August 2014
Computational prognostic indicators for breast cancer
Yang X, Ai X, Cunningham JM
Cancer Management and Research 2014, 6:301-312
Published Date: 12 July 2014
Prognostic stratification of colorectal cancer patients: current perspectives
Schneider NI, Langner C
Cancer Management and Research 2014, 6:291-300
Published Date: 2 July 2014
Update on benefit of immunotherapy and targeted therapy in melanoma: the changing landscape
Srivastava N, McDermott D
Cancer Management and Research 2014, 6:279-289
Published Date: 20 June 2014
Molecular effects of bioactive fraction of Curcuma mangga (DLBS4847) as a downregulator of 5α-reductase activity pathways in prostatic epithelial cells
Karsono AH, Tandrasasmita OM, Tjandrawinata RR
Cancer Management and Research 2014, 6:267-278
Published Date: 6 June 2014
High plasma exposure to pemetrexed leads to severe hyponatremia in patients with advanced non small cell lung cancer receiving pemetrexed-platinum doublet chemotherapy
Gota V, Kavathiya K, Doshi K, Gurjar M, Damodaran SE, Noronha V, Joshi A, Prabhash K
Cancer Management and Research 2014, 6:261-265
Published Date: 4 June 2014
Presentation and management of docetaxel-related adverse effects in patients with breast cancer
Ho MY, Mackey JR
Cancer Management and Research 2014, 6:253-259
Published Date: 27 May 2014
Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancer
May FEB
Cancer Management and Research 2014, 6:225-252
Published Date: 23 May 2014
Future of bisphosphonates and denosumab for men with advanced prostate cancer
Iranikhah M, Stricker S, Freeman MK
Cancer Management and Research 2014, 6:217-224
Published Date: 3 May 2014
Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives
Díaz-López A, Moreno-Bueno G, Cano A
Cancer Management and Research 2014, 6:205-216
Published Date: 25 April 2014
Genetic factors and breast cancer laterality
Amer MH
Cancer Management and Research 2014, 6:191-203
Published Date: 16 April 2014
A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation
Mason JW, Moon TE, O’Boyle E, Dietz A
Cancer Management and Research 2014, 6:181-190
Published Date: 26 March 2014
Emerging role for leucine-rich repeat-containing G-protein-coupled receptors LGR5 and LGR4 in cancer stem cells
Nakata S, Phillips E, Goidts V
Cancer Management and Research 2014, 6:171-180
Published Date: 24 March 2014
Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods
Ahmed R, Oborski MJ, Hwang M, Lieberman FS, Mountz JM
Cancer Management and Research 2014, 6:149-170
Published Date: 24 March 2014
Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature
Argyriou AA, Kyritsis AP, Makatsoris T, Kalofonos HP
Cancer Management and Research 2014, 6:135-147
Published Date: 19 March 2014
Multiple neoplasms, single primaries, and patient survival
Amer MH
Cancer Management and Research 2014, 6:119-134
Published Date: 5 March 2014
Fertility preservation during cancer treatment: clinical guidelines
Rodriguez-Wallberg KA, Oktay K
Cancer Management and Research 2014, 6:105-117
Published Date: 4 March 2014
Proactive strategies for regorafenib in metastatic colorectal cancer: implications for optimal patient management
Khan G, Moss RA, Braiteh F, Saltzman M
Cancer Management and Research 2014, 6:93-103
Published Date: 4 March 2014
DNA repair in cancer: emerging targets for personalized therapy
Abbotts R, Thompson N, Madhusudan S
Cancer Management and Research 2014, 6:77-92
Published Date: 19 February 2014
New modalities of cancer treatment for NSCLC: focus on immunotherapy
Davies M
Cancer Management and Research 2014, 6:63-75
Published Date: 3 February 2014
Decitabine in the treatment of acute myeloid leukemia in elderly patients
Malik P, Cashen AF
Cancer Management and Research 2014, 6:53-61
Published Date: 3 February 2014
Abiraterone in the treatment of metastatic castration-resistant prostate cancer
Mostaghel EA
Cancer Management and Research 2014, 6:39-51
Published Date: 28 January 2014
Developments in Burkitt's lymphoma: novel cooperations in oncogenic MYC signaling
Spender LC, Inman GJ
Cancer Management and Research 2014, 6:27-38
Published Date: 9 January 2014
MicroRNA function and dysregulation in bone tumors: the evidence to date
Nugent M
Cancer Management and Research 2014, 6:15-25
Published Date: 7 January 2014
Real-world impact of education: treating patients with ipilimumab in a community practice setting
Ledezma B, Heng A
Cancer Management and Research 2014, 6:5-14
Published Date: 21 December 2013
Marked radiographic response of a HER-2-overexpressing biliary cancer to trastuzumab
Sorscher S
Cancer Management and Research 2014, 6:1-3
Published Date: 11 December 2013